Wellbeing & Workforce

Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer

Exubrion Therapeutics has promoted Gregory Taglialatela, MBA, to Chief Commercial Officer, where he will lead the company’s commercial strategy as it continues expanding access to Synovetin OA®, its injectable treatment for canine osteoarthritis. Taglialatela assumes responsibility for national sales, key account management, business development and strategic growth initiatives effective July 1, 2026.

Purgo Scientific Names Dr. Cherice Roth CEO to Accelerate Growth of Vetlen and Localized Drug Delivery Platform

Purgo Scientific and its veterinary subsidiary, Vetlen, have appointed Dr. Cherice Roth, DVM, MS, MBA, as chief executive officer. A veterinarian, executive, inventor, and author, Roth brings leadership experience from Mars Veterinary Health, Fuzzy, and KeraVet Bio as she takes the helm of the medical technology company. She will oversee the continued commercialization of Vetlen’s refillable localized therapeutic delivery platform for veterinary medicine while guiding Purgo Scientific’s broader strategy to expand the technology into human healthcare. Company leaders said her background in clinical practice, innovation, digital health, and business leadership positions the organization for its next phase of growth.

Dr. Rosemary Sifford Receives 2026 AVMA Public Service Award

The American Veterinary Medical Association has named recently retired U.S. Chief Veterinary Officer Dr. Rosemary Sifford as the recipient of its 2026 Public Service Award, recognizing her decades of leadership in animal health and public service.

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.